Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.
Saved in:
| Title: | Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer. |
|---|---|
| Authors: | Ketch PW; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Scalise CB; Natera, Inc, Austin, TX., Recio F; AdventHealth Cancer Institute, Orlando, FL., Berman T; Inova Schar Cancer Institute, Fairfax, VA., Hook N; Natera, Inc, Austin, TX., Loar P; Texas Oncology, Austin, TX., Arend R; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Dutta P; Natera, Inc, Austin, TX., Gentry ZL; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Kalashnikova E; Natera, Inc, Austin, TX., Malhotra M; Natera, Inc, Austin, TX., Liu MC; Natera, Inc, Austin, TX., Vaccarello L; Zangmeister Cancer Center, Columbus, OH., ElNaggar AC; Natera, Inc, Austin, TX., Holloway R; AdventHealth Cancer Institute, Orlando, FL., Toboni MD; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2025 Sep; Vol. 9, pp. e2500286. Date of Electronic Publication: 2025 Sep 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
